Alzheimers

Alzheimers

Alzheimers

Infrared light therapy for the prevention of symptoms of Alzheimers?
Infrared light therapy for the prevention of symptoms of Alzheimers?
Infrared light therapy for the prevention of symptoms of Alzheimers?
Alzheimer's disease is a devastating condition. Both for the sufferer and the family and friends that are left behind.
Alzheimer's disease is a devastating condition. Both for the sufferer and the family and friends that are left behind.
Alzheimer's disease is a devastating condition. Both for the sufferer and the family and friends that are left behind.
Alzheimer's is a type of dementia (a general term for memory loss and a decline in other cognitive abilities ) serious enough that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. 

It is the most common form of dementia. 

Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Approximately 200,000 Americans under the age of 65 have younger-onset Alzheimer’s disease (also known as early-onset Alzheimer’s). 

Alzheimer's is a progressive disease, where dementia symptoms gradually worsen over a number of years. In its early stages, memory loss is mild, but with late-stage Alzheimer's, individuals lose the ability to carry on a conversation and respond to their environment. Alzheimer's is the sixth leading cause of death in the United States.
Alzheimer's is a type of dementia (a general term for memory loss and a decline in other cognitive abilities ) serious enough that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. 

It is the most common form of dementia. 

Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Approximately 200,000 Americans under the age of 65 have younger-onset Alzheimer’s disease (also known as early-onset Alzheimer’s). 

Alzheimer's is a progressive disease, where dementia symptoms gradually worsen over a number of years. In its early stages, memory loss is mild, but with late-stage Alzheimer's, individuals lose the ability to carry on a conversation and respond to their environment. Alzheimer's is the sixth leading cause of death in the United States.
Alzheimer's is a type of dementia (a general term for memory loss and a decline in other cognitive abilities ) serious enough that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. 

It is the most common form of dementia. 

Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Approximately 200,000 Americans under the age of 65 have younger-onset Alzheimer’s disease (also known as early-onset Alzheimer’s). 

Alzheimer's is a progressive disease, where dementia symptoms gradually worsen over a number of years. In its early stages, memory loss is mild, but with late-stage Alzheimer's, individuals lose the ability to carry on a conversation and respond to their environment. Alzheimer's is the sixth leading cause of death in the United States.

According to alz.org - 

An estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018. This number includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s.


In the UK the numbers are, proportionally, equally shocking. 


There are 850,000 people with dementia in the UK, with numbers set to rise to over 1 million by 2025. This will soar to 2 million by 2051.


225,000 will develop dementia this year, that’s one every three minutes.


There are over 40,000 people under 65 with dementia in the UK.

According to alz.org - 

An estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018. This number includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s.


In the UK the numbers are, proportionally, equally shocking. 


There are 850,000 people with dementia in the UK, with numbers set to rise to over 1 million by 2025. This will soar to 2 million by 2051.


225,000 will develop dementia this year, that’s one every three minutes.


There are over 40,000 people under 65 with dementia in the UK.

According to alz.org - 

An estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018. This number includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s.


In the UK the numbers are, proportionally, equally shocking. 


There are 850,000 people with dementia in the UK, with numbers set to rise to over 1 million by 2025. This will soar to 2 million by 2051.


225,000 will develop dementia this year, that’s one every three minutes.


There are over 40,000 people under 65 with dementia in the UK.

In Alzheimer’s, there are changes in the brain beyond those associated with normal ageing.


Among the most prominent are the build-up of two proteins, called amyloid-beta and tau. Research suggests that both of these are involved in the disease process, and is revealing more about the sequence of events. As the disease progresses, more and more nerve cells in the brain become damaged. This damage leads to the symptoms of Alzheimer’s

 

An interesting study suggests that there may be reason to believe that infrared light therapy on the head may lead to a decrease in the symptoms of Alzheimer’s Disease.

In Alzheimer’s, there are changes in the brain beyond those associated with normal ageing.


Among the most prominent are the build-up of two proteins, called amyloid-beta and tau. Research suggests that both of these are involved in the disease process, and is revealing more about the sequence of events. As the disease progresses, more and more nerve cells in the brain become damaged. This damage leads to the symptoms of Alzheimer’s

 

An interesting study suggests that there may be reason to believe that infrared light therapy on the head may lead to a decrease in the symptoms of Alzheimer’s Disease.

In Alzheimer’s, there are changes in the brain beyond those associated with normal ageing.


Among the most prominent are the build-up of two proteins, called amyloid-beta and tau. Research suggests that both of these are involved in the disease process, and is revealing more about the sequence of events. As the disease progresses, more and more nerve cells in the brain become damaged. This damage leads to the symptoms of Alzheimer’s

 

An interesting study suggests that there may be reason to believe that infrared light therapy on the head may lead to a decrease in the symptoms of Alzheimer’s Disease.

The details of a study (1) reported in Scientific Reports, from a US University (2) shows a significant reduction in the harmful effects, related to Alzheimers in the brain, after a period of treatment with infrared light on the heads of mice. 


Researchers at the university recently found that a certain type of protein can become toxic at the point of connection between brain cells where information gets passed along. This break down between brain cells is known to be a sign of the onset of the disease.


Infrared light has been shown to reduce the occurrence of this protein which suggests that infrared light can be used therapeutically to treat the disease.


The senior author of the study, Giulio Taglialatela, is quoted as saying, “Near infrared light therapy increases the health of the points of connection between brain cells, thus decreasing the susceptibility to the toxic proteins.

The details of a study (1) reported in Scientific Reports, from a US University (2) shows a significant reduction in the harmful effects, related to Alzheimers in the brain, after a period of treatment with infrared light on the heads of mice. 


Researchers at the university recently found that a certain type of protein can become toxic at the point of connection between brain cells where information gets passed along. This break down between brain cells is known to be a sign of the onset of the disease.


Infrared light has been shown to reduce the occurrence of this protein which suggests that infrared light can be used therapeutically to treat the disease.


The senior author of the study, Giulio Taglialatela, is quoted as saying, “Near infrared light therapy increases the health of the points of connection between brain cells, thus decreasing the susceptibility to the toxic proteins.

The details of a study (1) reported in Scientific Reports, from a US University (2) shows a significant reduction in the harmful effects, related to Alzheimers in the brain, after a period of treatment with infrared light on the heads of mice. 


Researchers at the university recently found that a certain type of protein can become toxic at the point of connection between brain cells where information gets passed along. This break down between brain cells is known to be a sign of the onset of the disease.


Infrared light has been shown to reduce the occurrence of this protein which suggests that infrared light can be used therapeutically to treat the disease.


The senior author of the study, Giulio Taglialatela, is quoted as saying, “Near infrared light therapy increases the health of the points of connection between brain cells, thus decreasing the susceptibility to the toxic proteins.